BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 18830204)

  • 1. Safety and tolerability of 600 mg clopidogrel bolus in patients with acute ischemic stroke: preliminary experience.
    Suri MF; Hussein HM; Abdelmoula MM; Divani AA; Qureshi AI
    Med Sci Monit; 2008 Oct; 14(10):PI39-44. PubMed ID: 18830204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A; Dzialowski I; Koch R; Gahn G
    J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial change in platelet activation markers with aspirin and clopidogrel after acute ischemic stroke.
    Tsai NW; Chang WN; Shaw CF; Jan CR; Chang HW; Huang CR; Chen SD; Chuang YC; Lee LH; Lu CH
    Clin Neuropharmacol; 2010; 33(1):40-5. PubMed ID: 19855266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of persistence with antiplatelet therapy on recurrent ischemic stroke and predictors of nonpersistence among ischemic stroke survivors.
    Burke JP; Sander S; Shah H; Zarotsky V; Henk H
    Curr Med Res Opin; 2010 May; 26(5):1023-30. PubMed ID: 20199138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding aspirin to clopidogrel after TIA and ischemic stroke: benefits do not match risks.
    Hankey GJ; Eikelboom JW
    Neurology; 2005 Apr; 64(7):1117-21. PubMed ID: 15824331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of platelet aggregation during antiplatelet therapy in ischemic stroke.
    Pongrácz E
    Clin Hemorheol Microcirc; 2004; 30(3-4):237-42. PubMed ID: 15258349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the thromboxane prostaglandin receptor antagonist terutroban on arterial thrombogenesis after repeated administration in patients treated for the prevention of ischemic stroke.
    Bal Dit Sollier C; Crassard I; Simoneau G; Bergmann JF; Bousser MG; Drouet L
    Cerebrovasc Dis; 2009; 28(5):505-13. PubMed ID: 19752552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
    Sztriha LK; Vécsei L
    Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving perspectives on clopidogrel in the treatment of ischemic stroke.
    Gorelick P; Sechenova O; Hennekens CH
    J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):245-8. PubMed ID: 17220470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of previous antiplatelet drug use in patients with new or recurrent ischemic stroke: Buffalo metropolitan area and Erie County stroke study.
    Qureshi AI; Kirmani JF; Safdar A; Ahmed S; Sayed MA; Pande RU; Ferguson R; Hershey LA; Qazi KJ
    Pharmacotherapy; 2006 Apr; 26(4):493-8. PubMed ID: 16553507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J
    J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MATCH results: implications for the internist.
    Lutsep HL
    Am J Med; 2006 Jun; 119(6):526.e1-7. PubMed ID: 16750967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet drugs for ischemic stroke prevention.
    Leys D; Balucani C; Cordonnier C
    Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet agents and randomized trials.
    Diener HC
    Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of antiplatelet therapy in cardiovascular disease II: Ischemic stroke.
    Cavendish JJ; Cramer SC; Graham GD
    Curr Med Res Opin; 2004 Nov; 20(11):1845-9. PubMed ID: 15537485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: subgroup analysis of the CHARISMA randomized trial.
    Hart RG; Bhatt DL; Hacke W; Fox KA; Hankey GJ; Berger PB; Hu T; Topol EJ;
    Cerebrovasc Dis; 2008; 25(4):344-7. PubMed ID: 18303254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
    Diener HC
    Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.